WAG
ABBV icon

Wiser Advisor Group’s AbbVie ABBV Stock Holding History

Wiser Advisor Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26K Buy
103
+1
+1% +$215 0.03% 124
2026
Q1 		$22.3K Hold
102
– – 0.03% 123
2025
Q4 		$23.2K Buy
102
+1
+1% +$228 0.03% 127
2025
Q3 		$23.4K Buy
+101
New +$20.6K 0.03% 129
2025
Q2 		– Sell
-99
Closed -$20.8K – 41
2025
Q1 		$20.8K Buy
99
+1
+1% +$194 0.03% 145
2024
Q4 		$17.5K Buy
98
+1
+1% +$184 0.03% 153
2024
Q3 		$19.2K Buy
97
+1
+1% +$187 0.03% 158
2024
Q2 		$16.6K Buy
96
+1
+1% +$166 0.03% 164
2024
Q1 		$17.4K Hold
95
– – 0.03% 157
2023
Q4 		$14.7K Buy
+95
New +$13.8K 0.02% 167

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wiser Advisor Group's ABBV Position: Q2 2026 in Review

Wiser Advisor Group increased its AbbVie (ABBV) stake by 0.98% in Q2 2026, buying an estimated $215 and bringing the position to 103 shares worth $26K. The position accounts for 0.03% of the portfolio, ranked #124.

Wiser Advisor Group first reported a position in ABBV in Q4 2023 and has held it in 10 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Wiser Advisor Group held 103 shares of AbbVie worth $26K as of Q2 2026.
  • Wiser Advisor Group bought 1 AbbVie share in Q2 2026, an estimated $215.
  • AbbVie made up 0.03% of Wiser Advisor Group's portfolio in Q2 2026, its #124 holding.
  • Wiser Advisor Group first reported a position in AbbVie in Q4 2023 and has held it in 10 quarters since.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Wiser Advisor Group's 13F filing for Q2 2026, filed 17 Aug 2026.